Status:
ACTIVE_NOT_RECRUITING
Cohort of Hospitalized Patients Suspected of Leptospirosis
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Leptospirosis
Eligibility:
All Genders
1+ years
Phase:
NA
Brief Summary
COLEPT is a prospective interventional study that intends to better inform about leptospirosis, a neglected zoonotic infectious disease. During prospective follow-up of hospitalized acute leptospirosi...
Eligibility Criteria
Inclusion
- clinico-biological manifestations compatible with acute leptospirosis OR proven leptospirosis with serological testing or PCR
- onset of symptoms within 21 days
- participant benefits of health insurance
Exclusion
- participant's refusal, or refusal from his relatives in case of major incapacity of the eligible participant precluding expression of his will (coma, stay in intensive care unit))
Key Trial Info
Start Date :
January 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04034550
Start Date
January 6 2021
End Date
July 1 2027
Last Update
July 30 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Est Réunion (GHER)
Saint-Benoît, Reunion, France, 97470
2
CHU de La Réunion site Nord
Saint-Denis, Reunion, France, 97400
3
Centre Hospitalier Ouest Réunion (CHOR)
Saint-Paul, Reunion, France, 97460
4
CHU de La Réunion site Sud (GHSR)
Saint-Pierre, Reunion, France, 97410